Who
Yishan Li
Executive Chairman
Company insider
Files Form 4 as: Executive Chairman, BlossomHill Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Aug 2026
- Last trade
- 10 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Code C | —1,600,682 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Code C | —113,435 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Code C | —124,779 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,600,682 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —113,435 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —124,779 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,600,682 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —113,435 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —124,779 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Code C | —1,600,682 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Code C | —113,435 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Code C | —124,779 | filing |
| 6 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —112,701 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —112,701 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.